Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction

Japanese Journal of Cancer Research

Volumn 90, Issue 3, 1999, Pages 349-354

  Inaba, Makoto ^a   Sawada, Hiroko ^a   Sadata, Akiko ^a   Hamada, Hirofumi ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

5 Fluorouracil; Adenoviral vector; Drug resistance; Gene therapy; Uracil phosphoribosyltransferase

Indexed keywords

FLUOROURACIL; OROTATE PHOSPHORIBOSYLTRANSFERASE; URACIL PHOSPHORIBOSYLTRANSFERASE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG METABOLISM; DRUG SENSITIVITY; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER;

EID: 0032955244     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00754.x     Document Type: Article

References (25)

1. Aschele, C., Sobrero, A., Faderan, M. A. and Bertino, J. R. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res., 52, 1855-1864 (1992).
2. Wang, F.-S., Aschele, C., Sobrero, A., Chang, Y.-M. and Bertino, J. R. Decreased folypolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance. Cancer Res., 53, 3677-3680 (1993).
3. Lesuffleur, T., Kornowski, A., Luccioni, C., Muleris, M., Barbat, A., Beaumatin, J., Dussaulx, E., Dutrillaux, B. and Zweibaum, A. Adaptation to 5-fluorouracil of the heterogenous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int. J. Cancer, 49, 721-730 (1991).
4. Copur, S., Aiba, K., Drake, J. C., Allegra, C. J. and Chu, E. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem. Pharmacol., 49, 1419-1426 (1995).
5. Pizzorno, G. and Handschumacher, R. E. Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines. Biochem. Pharmacol., 49, 559-565 (1995).
6. Findenig, G., Mader, R. M., Fritzer-Szekeres, M., Steger, G. G., Jaeger, W. and Szekeres, T. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azido-thymidine. Oncol Res., 8, 189-196 (1996).
7. Inaba, M., Mitsuhashi, J., Sawada, H., Miike, N., Naoe, Y., Daimon, A., Koizumi, K., Tsujimoto, H. and Fukushima, M. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Jpn. J. Cancer Res., 87, 212-220 (1996).
8. Inaba, M., Tanaka, T. and Sawada, H. Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure. Jpn. J. Cancer Res. ,89, 323-327 (1998).
9. Inaba, M., Naoe, Y. and Mitsuhashi, J. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells. Biol. Pharm. Bull., 21, 569-573 (1998).
10. Roth, J. A. and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 88, 21-39 (1997).
11. Hapke, D. M., Stegmann, A. P. A. and Mitchell, B. S. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity. Cancer Res., 56, 2343-2347 (1996).
12. Manome, Y., Wen, P. Y., Dong, Y., Tanaka, T., Mitchell, B. S., Kufe, D. W. and Fine, H. A. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat. Med., 2, 567-573 (1996).
13. Kanai, F., Kawakami, T., Hamada, H., Sadata, A., Yoshida, Y., Tanaka, T., Ohashi, M., Shiratori, Y. and Omata, M. Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyl-transferase gene sensitizes cancer cells to low concentration of 5-fluorouracil in vitro and in vivo. Cancer Res., 58, 1946-1951 (1998).
14. Kanai, F., Shiratori, Y., Yoshida, Y., Wakimoto, H., Hamada, H., Kanegae, Y., Saito, I., Nakabayashi, H., Tamaoki, T., Tanaka, T., Lan, K.-H., Kato, N., Shiina, S. and Omata, M. Gene therapy for α-fetoprotein producing human hepatoma cells by adenovirus-mediated transfer of herpes simplex virus thymidine kinase gene. Hepatology, 23, 1359-1368 (1996).
15. Tanaka, T., Kanai, F., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Shiratori, Y., Lan, K.-H., Ishitobi, M. and Omata, M. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res., 56, 1341-1345 (1996).
16. Peters, G. J., Laurensse, E., Leyva, A., Lankelma, J. and Pinedo, H. M. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res., 46, 20-28 (1986).
17. Loenn, U. and Loenn, S. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma. Cancer Res., 44, 3414-3418 (1984).
18. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minutena, J. D. and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 48, 589-601 (1988).
19. Grant, S. Ara-C: cellular and molecular pharmacology. In "Advances in Cancer Research," vol. 72, ed. G. F. V. Woude and G. Klein, pp. 197-233 (1998). Academic Press, New York.
20. Ruiz van Haperen, V. W. T., Veerman, G., Eriksson, S., Boven, E., Stegmann, A. P. A., Hermsen, M., Vermorken, J. B., Pinedo, H. M. and Peters, G. J. Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. Cancer Res., 54, 4138-4143 (1994).
21. Lenz, H.-J., Leichman, C. G., Danenberg, K. D., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li., J. and Leichman, L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14, 176-182 (1996).
22. Leichman, C. G., Lenz, H.-J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M. and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol., 15, 3223-3229 (1997).
23. Stegmann, A. P. A., Honders, W. H., Willemze, R., Ruiz van Haperen, V. W. T. and Landegent, J. E. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an ara-C and DAC-resistant rat leukemia cell line of clonal origin fully restores drug sensitivity. Blood, 85, 1188-1194 (1995).
24. Inaba, M., Mitsuhashi, J. and Ozawa, S. Kinetic analysis of 5-fluorouracil action against various cancer cells. Jpn. J. Cancer Res., 81, 1039-1044 (1990).
25. Inaba, M. and Mitsuhashi, J. Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells. Oncol. Res., 6, 303-309 (1994).